MOL CANCER 润色咨询

Molecular Cancer

出版年份:2002 年文章数:971 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:2.0% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊简介

期刊简介
GetPortalImpactFactorByIdResp(projectId=1, id=b4d34816, cover=https://img.medsci.cn/images/journal/cover/2021/Bsz_202109271316060760.jpg, fullname=Molecular Cancer, abbr=MOL CANCER, pyear=2002, frequence=Irregular, articleNumbers=971, citedSelf2015=2.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均3.66月, reviewFee=null, pageFee=4290.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=1476-4598, greenSci=https://www.greensci.net/search?kw=1476-4598, scijournal=https://www.scijournal.org/impact-factor-of-MOL-CANCER.shtml, medsciHotlightString=null, medsciHotlightRealtime=21.295, medsciHotlight=33.812, medsciHotlight5year=34.9044, citescore=34.3, hIndex=126, impactFactor=37.3, orgnization=BioMed Central Ltd., orgnizationUrl=http://www.biomedcentral.com/, country=United Kingdom, countryCn=英国, isOa=1, isOaString=是, sciScie=Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews, bigclassCas=医学 1区[Top], smallclassCas=, website=https://molecular-cancer.biomedcentral.com/?utm_source=medsci&utm_medium=display&utm_content=text_link&utm_campaign=BSCN_4_CZ01_CN_organic_MedSci_2020_HomePage, websiteHits=25345, guideForAuthor=https://molecular-cancer.biomedcentral.com/submission-guidelines?utm_source=medsci&utm_medium=display&utm_content=text_link&utm_campaign=BSCN_3_CZ01_CN_organic_MedSci_2020_publish, guideForAuthorHits=2289, submitWebsite=https://www.editorialmanager.com/molc/default.aspx, submitWebsiteHits=9911, content=<p>Published by BioMed Central. ISSN: 1476-4598.<br /><br />Molecular Cancer is an Open Access, peer-reviewed online journal interested in original research and commentary in all areas of cancer and related biomedical science. Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Molecular Cancer will consider articles from any area of cancer-related biomedical research, including, but not limited to: angiogenesis; animal models; metastasis; cancer antigens and the immune response to them; cellular signalling and molecular biology; epidemiology; genetic and molecular profiling of cancer; prevention, diagnosis and therapy of cancer; and vaccine- and antibody-based cancer therapies. Molecular Cancer, a forum for exciting findings in the field of cancer-related research, is an Open Access journal, providing an unparalleled opportunity to present information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information.</p>, totalCites=36241, brief=MOL CANCER杂志医学行业,“<strong><a target="_blank" href="/sci/index.do?smallclass=生化与分子生物学" >生化与分子生物学</a></strong>”子行业的中等级别杂志, articleType=论著为主,其它类型文章约占5-10%, medsciHeat=<span style="color: #990000;">暗红</span>, medsciComment=MOL CANCER 在该细分领域可能是国际一流杂志,但是国内关注少,可能与很难投中有关吧,可以试试,但不要报过高中的期望哦。, medsciExplanation=MedSci期刊指数是根据中国科研工作者(含医学临床,基础,生物,化学等学科)对SCI杂志的认知度,熟悉程度,以及投稿的量等众多指标综合评定而成。当然,具体的,您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=b4d34816'>投稿经验系统</a>”,进行综合判断,这更是大家的实战经验,值得分享和参考。<br> 注意,上述MedSci期刊指数采用MedSci专利技术,由计算机系统自动计算,并给出建议,存在不准确的可能,仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=100), ImpactFactorTagDto(id=30949, tagName=circRNA, createdHits=16), ImpactFactorTagDto(id=5669, tagName=肿瘤微环境, createdHits=9), ImpactFactorTagDto(id=19505, tagName=肿瘤生物学, createdHits=8), ImpactFactorTagDto(id=121, tagName=Immunology, createdHits=7), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=6), ImpactFactorTagDto(id=721, tagName=靶向治疗, createdHits=6), ImpactFactorTagDto(id=13403, tagName=lncRNA, createdHits=6), ImpactFactorTagDto(id=74708, tagName=CAF, createdHits=5), ImpactFactorTagDto(id=429, tagName=肝癌, createdHits=5), ImpactFactorTagDto(id=15976, tagName=外泌体, createdHits=4), ImpactFactorTagDto(id=516, tagName=癌症, createdHits=4), ImpactFactorTagDto(id=19550, tagName=非编码, createdHits=3), ImpactFactorTagDto(id=990, tagName=基因, createdHits=3), ImpactFactorTagDto(id=4825, tagName=肠癌, createdHits=3), ImpactFactorTagDto(id=5431, tagName=肿瘤转移, createdHits=3), ImpactFactorTagDto(id=37295, tagName=肿瘤化疗, createdHits=3), ImpactFactorTagDto(id=2211, tagName=缺氧, createdHits=2), ImpactFactorTagDto(id=15372, tagName=表观遗传, createdHits=2), ImpactFactorTagDto(id=55882, tagName=caner, createdHits=2), ImpactFactorTagDto(id=51675, tagName=gastric cancer, createdHits=2), ImpactFactorTagDto(id=615, tagName=血管新生, createdHits=2), ImpactFactorTagDto(id=5046, tagName=非编码RNA, createdHits=2), ImpactFactorTagDto(id=50246, tagName=noncoding RNA, createdHits=1), ImpactFactorTagDto(id=44274, tagName=invasion, createdHits=1), ImpactFactorTagDto(id=438, tagName=胃癌, createdHits=1), ImpactFactorTagDto(id=111546, tagName= 血管新生 , createdHits=1), ImpactFactorTagDto(id=111545, tagName= lncRNA , createdHits=1), ImpactFactorTagDto(id=111544, tagName= Cancer , createdHits=1), ImpactFactorTagDto(id=4713, tagName=EMT, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2016, citescore=6.27), GetImpactFactorCiteScoreListResponse(year=2017, citescore=7.2), GetImpactFactorCiteScoreListResponse(year=2018, citescore=9.17), GetImpactFactorCiteScoreListResponse(year=2019, citescore=19.0), GetImpactFactorCiteScoreListResponse(year=2020, citescore=34.3)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=34.772), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=38.793), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=35.53), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=21.874), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=21.295)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Cancer Research , rank=6/191), GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Oncology , rank=7/321), GetImpactFactorCiteScoreGradeResponse(smallClass=Biochemistry, Genetics and Molecular Biology - Molecular Medicine , rank=4/165)], totalJcrAreaList=[GetImpactFactorCiteScoreGradeResponse(smallClass=BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE/ONCOLOGY - SCIE, rank=BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE/ONCOLOGY - SCIE)], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4598[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=MOLECULAR CANCER[ta], article_number=229, article_number_cn=159, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)
期刊名称
MOL CANCER/Molecular Cancer
ISSN
1476-4598
影响指数话题
预警等级
MedSci期刊指数
21.295 (MedSci实时期刊指数) | 34.9044 (5年期刊指数)
CiteScore值
34.3
h-index
126
h5-median
暂无数据
出版社/管理机构
杂志由 BioMed Central Ltd. 出版或管理
出版国家/地区
United Kingdom 英国
出版周期
Irregular
出版年份
2002
是否OA
被收录情况
Science Citation Index Expanded|Current Contents - Life Sciences|BIOSIS Previews
JCR分区
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE/ONCOLOGY - SCIE BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE/ONCOLOGY - SCIE
中科院分区
大类:医学 1区[Top]
小类: